Molecular imaging in drug developmentAdvancing the development of tuberculosis therapyParadigm shift in neuroprotection by NMDA receptor blockade: Memantine and beyondIntegrative knowledge management to enhance pharmaceutical R&DIs NF-kappaB a good target for cancer therapy? Hopes and pitfallsSoluble epoxide hydrolase as a therapeutic target for cardiovascular diseasesChloride channels as drug targets.Adenosine receptors as therapeutic targetsGenomic-scale prioritization of drug targets: the TDR Targets databaseAdenosine receptors: therapeutic aspects for inflammatory and immune diseases.NO-independent stimulators and activators of soluble guanylate cyclase: discovery and therapeutic potentialDNA vaccines against Zika virus speed into clinical trialsOpen data in drug discovery and development: lessons from malariaIntegrin-based therapeutics: biological basis, clinical use and new drugsSingle-cell analysis tools for drug discovery and developmentA holistic approach to targeting disease with polymeric nanoparticlesThe pharmacological landscape and therapeutic potential of serine hydrolasesAutophagy modulation as a potential therapeutic target for diverse diseasesSLC transporters as therapeutic targets: emerging opportunitiesThe two faces of Hippo: targeting the Hippo pathway for regenerative medicine and cancer treatmentHeat shock transcription factor 1 as a therapeutic target in neurodegenerative diseasesNew vaccine coalition targets epidemicsMicrotubule-binding agents: a dynamic field of cancer therapeutics.The genetics of the p53 pathway, apoptosis and cancer therapy.Precompetitive activity to address the biological data needs of drug discoveryOrgans-on-chips at the frontiers of drug discovery3D cell technologies head to the R&D assembly linePotential cardioprotective actions of no-releasing aspirinScientific and therapeutic advances in antiplatelet therapyPI3Kgamma inhibition: towards an 'aspirin of the 21st century'?Hit and lead generation: beyond high-throughput screeningModern biomedical research: an internally self-consistent universe with little contact with medical reality?Therapeutic potential of venom peptidesThe trouble with making combination drugsThe emergence of the drug receptor theoryThe evolving role of natural products in drug discoveryTargeting bromodomains: epigenetic readers of lysine acetylationEmerging targets in neuroinflammation-driven chronic painTransient receptor potential channels as therapeutic targetsAchilles heel of Ebola viral entry
P1433
Q22122025-DFEB30F9-2DBF-4712-864A-65197BB96F83Q22251041-BF887B14-FC8F-4D9D-8B38-2F2CEF86AD54Q22251042-8C3A47F1-421F-4B62-A781-35139512FE70Q22676712-CDA39778-4070-4B3B-8C29-917289FA5C47Q24570128-997CE034-BDDB-4EFD-893F-B7FDCD4D6069Q24597172-701B24D5-3A62-41AA-9C21-0F776D6A990BQ24601830-049D1D98-A25E-4F31-A4C0-A9CEFE86DF07Q24632095-D80F2BBA-EB8F-44CC-9C8E-D967553EDD65Q24635333-552B0FCD-1B4E-4C8F-B713-7B807AC76D71Q24651475-B1D6C8F8-EACA-44FE-9EF3-D3F8B6E80032Q24656131-6119E114-7BBB-49C3-A4C7-4D40E11F61D4Q26247186-E49BD076-0E20-417F-83CB-F3AB9A49D596Q26742211-62BD4753-7A83-49E1-A96E-81F305D163D7Q26773026-D9BD6455-21A1-4683-B1F3-F01F3B9BCB59Q26775754-36514E35-B298-4D1D-B692-DAEFF3102EE9Q26865163-53B2052B-6114-44B8-A24C-9A73FE61B55EQ26995817-3F33AAB5-CF3E-48EA-8071-67E1648F24DFQ27010076-A752C4C4-2F8C-4B57-9B02-6265B8770E23Q27014726-D0D92DFF-CBA8-45F9-9A27-A635FF292095Q27025661-49C0D5A6-910A-449A-9F2E-A93CF9B5862BQ27026884-376AC969-ACB3-4AB9-9BA7-8181C8B756CBQ27134242-42456CA7-4AB6-4E4B-8C5A-BFF9A2ACC234Q27690249-84ADFD95-F900-49B8-BAF6-12967883C832Q27863460-B972C4AD-635D-4B47-AC8C-F5F7F5D7FEB7Q27967886-E08028D7-43D8-4B49-A0AA-732F554EF28EQ28083671-429D5F27-498D-4091-B8CF-6D66CE035822Q28114588-9D5DA588-A85F-4273-8430-466D796F3EDCQ28193422-DB64BCC8-811B-438D-92D5-E6D280AB0D9BQ28194547-1D33C170-1485-4C1D-B37B-FD9D067C0F11Q28201583-3E992F38-248C-4DF1-AA8E-F92F1165EE2DQ28204526-8693642B-3923-4FDA-8E6C-09371B76657AQ28206781-1ACF3A41-25C2-4C51-9295-A792D44601AAQ28207222-BEC66DEA-822D-4ABF-A61D-A33B05679FFFQ28210843-7428F346-364C-45BA-BE18-5DF88D92CDE6Q28211337-A497E157-AC28-48A6-A0A7-67F4EBC6BDC3Q28236671-D6B217CA-060A-45C3-8184-86DDD396499CQ28238635-338A5444-50B2-454E-A192-CD8E3738B9F0Q28242435-EF6E7BE3-7D8F-4AE2-A905-B368E78998F2Q28244558-BA2D82BB-FEFA-461D-AA0F-6E4ECA1EDB9CQ28249325-746729C7-46DB-4FA0-A778-79F503660D95
P1433
description
englische Pharmakologiezeitschrift
@de
journal
@en
revista científica
@es
vědecký časopis
@cs
wetenschappelijk tijdschrift van Nature Publishing Group
@nl
مجلة
@ar
वैज्ञानिक पत्रिका
@hi
英语期刊
@zh
name
Nature Reviews Drug Discovery
@ast
Nature Reviews Drug Discovery
@ca
Nature Reviews Drug Discovery
@da
Nature Reviews Drug Discovery
@de
Nature Reviews Drug Discovery
@en
Nature Reviews Drug Discovery
@es
Nature Reviews Drug Discovery
@fi
Nature Reviews Drug Discovery
@fo
Nature Reviews Drug Discovery
@fr
Nature Reviews Drug Discovery
@id
type
label
Nature Reviews Drug Discovery
@ast
Nature Reviews Drug Discovery
@ca
Nature Reviews Drug Discovery
@da
Nature Reviews Drug Discovery
@de
Nature Reviews Drug Discovery
@en
Nature Reviews Drug Discovery
@es
Nature Reviews Drug Discovery
@fi
Nature Reviews Drug Discovery
@fo
Nature Reviews Drug Discovery
@fr
Nature Reviews Drug Discovery
@id
altLabel
Nat Rev Drug Discov
@da
Nat Rev Drug Discov
@de
Nat Rev Drug Discov
@en
Nat Rev Drug Discov
@ru
Nat. Rev. Drug Discov.
@fr
Nat. Rev. Drug Discov.
@ru
Nature Reviews. Drug Discovery
@en
prefLabel
Nature Reviews Drug Discovery
@ast
Nature Reviews Drug Discovery
@ca
Nature Reviews Drug Discovery
@da
Nature Reviews Drug Discovery
@de
Nature Reviews Drug Discovery
@en
Nature Reviews Drug Discovery
@es
Nature Reviews Drug Discovery
@fi
Nature Reviews Drug Discovery
@fo
Nature Reviews Drug Discovery
@fr
Nature Reviews Drug Discovery
@id
P243
P3181
P4616
P646
P1055
P1058
P1144
2002243044
P1156
P1159
P1160
Nat. Rev. Drug Discov.
P1277
P1476
Nature Reviews Drug Discovery
@en
P1813
Nat Rev Drug Discov
@en